[{"id":60,"tag_name":"STATUS","tag_value":"[1.0.0.0] - Unrelated Normal Control","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:49Z","updated_at":"2013-10-21T12:37:49Z","description":null},{"id":61,"tag_name":"STATUS","tag_value":"[1.0.1.0] - Unrelated Normal Control,,Patient-derived Tissue,","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:49Z","updated_at":"2013-10-21T12:37:49Z","description":null},{"id":62,"tag_name":"STATUS","tag_value":"[1.0.2.0] - Unrelated Normal Control,,(Sorted) Primary cell population,","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:49Z","updated_at":"2013-10-21T12:37:49Z","description":null},{"id":63,"tag_name":"STATUS","tag_value":"[1.0.3.0] - Unrelated Normal Control,,Cell line,","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:49Z","updated_at":"2013-10-21T12:37:49Z","description":null},{"id":64,"tag_name":"STATUS","tag_value":"[2.0.0.0] - Disease state-derived","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:49Z","updated_at":"2013-10-21T12:37:49Z","description":null},{"id":65,"tag_name":"STATUS","tag_value":"[2.1.0.0] - Disease state-derived,Malignant","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:49Z","updated_at":"2013-10-21T12:37:49Z","description":null},{"id":66,"tag_name":"STATUS","tag_value":"[2.1.1.0] - Disease state-derived,Malignant,Patient-derived tissue","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":67,"tag_name":"STATUS","tag_value":"[2.1.1.1] - Disease state-derived,Malignant,Patient-derived tissue,Initial","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-24T15:51:00Z","description":""},{"id":68,"tag_name":"STATUS","tag_value":"[2.1.1.2] - Disease state-derived,Malignant,Patient-derived tissue,Remission","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-24T15:52:08Z","description":""},{"id":69,"tag_name":"STATUS","tag_value":"[2.1.1.3] - Disease state-derived,Malignant,Patient-derived tissue,Partial Remission","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":70,"tag_name":"STATUS","tag_value":"[2.1.1.4] - Disease state-derived,Malignant,Patient-derived tissue,Recurrent","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":71,"tag_name":"STATUS","tag_value":"[2.1.1.5] - Disease state-derived,Malignant,Patient-derived tissue,Control tissue","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":72,"tag_name":"STATUS","tag_value":"[2.1.1.6] - Disease state-derived,Malignant,Patient-derived tissue,Other (e.g. after BMT..)","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":73,"tag_name":"STATUS","tag_value":"[2.1.2.0] - Disease state-derived,Malignant,(Sorted) Primary cell population","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":74,"tag_name":"STATUS","tag_value":"[2.1.2.1] - Disease state-derived,Malignant,(Sorted) Primary cell population,Initial","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":75,"tag_name":"STATUS","tag_value":"[2.1.2.2] - Disease state-derived,Malignant,(Sorted) Primary cell population,Remission","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":76,"tag_name":"STATUS","tag_value":"[2.1.2.3] - Disease state-derived,Malignant,(Sorted) Primary cell population,Partial Remission","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":77,"tag_name":"STATUS","tag_value":"[2.1.2.4] - Disease state-derived,Malignant,(Sorted) Primary cell population,Recurrent","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":78,"tag_name":"STATUS","tag_value":"[2.1.2.5] - Disease state-derived,Malignant,(Sorted) Primary cell population,Control cells","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":79,"tag_name":"STATUS","tag_value":"[2.1.2.6] - Disease state-derived,Malignant,(Sorted) Primary cell population,Other (e.g. after BMT....)","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":80,"tag_name":"STATUS","tag_value":"[2.1.3.0] - Disease state-derived,Malignant,Cell line","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":81,"tag_name":"STATUS","tag_value":"[2.1.3.1] - Disease state-derived,Malignant,Cell line,Virally tranformed","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":82,"tag_name":"STATUS","tag_value":"[2.1.3.2] - Disease state-derived,Malignant,Cell line,Non-transformed","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":83,"tag_name":"STATUS","tag_value":"[2.2.0.0] - Disease state-derived,Immunedefect","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":84,"tag_name":"STATUS","tag_value":"[2.2.1.0] - Disease state-derived,Immunedefect,Affected","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":85,"tag_name":"STATUS","tag_value":"[2.2.1.1] - Disease state-derived,Immunedefect,Affected,Patient","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-11-14T15:37:33Z","description":""},{"id":86,"tag_name":"STATUS","tag_value":"[2.2.1.2] - Disease state-derived,Immunedefect,Affected,Sibbling","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":87,"tag_name":"STATUS","tag_value":"[2.2.1.3] - Disease state-derived,Immunedefect,Affected,Mother","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":88,"tag_name":"STATUS","tag_value":"[2.2.1.4] - Disease state-derived,Immunedefect,Affected,Father","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":89,"tag_name":"STATUS","tag_value":"[2.2.1.5] - Disease state-derived,Immunedefect,Affected,Other relatives","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":90,"tag_name":"STATUS","tag_value":"[2.2.2.0] - Disease state-derived,Immunedefect,Not-affected","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":91,"tag_name":"STATUS","tag_value":"[2.2.2.1] - Disease state-derived,Immunedefect,Not-affected,Sibbling","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":92,"tag_name":"STATUS","tag_value":"[2.2.2.2] - Disease state-derived,Immunedefect,Not-affected,Mother","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":93,"tag_name":"STATUS","tag_value":"[2.2.2.3] - Disease state-derived,Immunedefect,Not-affected,Father","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":94,"tag_name":"STATUS","tag_value":"[2.2.2.4] - Disease state-derived,Immunedefect,Not-affected,Other relatives","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":95,"tag_name":"STATUS","tag_value":"[2.3.0.0] - Disease state-derived,Other","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-11-04T15:19:09Z","description":""},{"id":96,"tag_name":"STATUS","tag_value":"[2.3.1.0] - Disease state-derived,Other,Affected","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:50Z","updated_at":"2013-10-21T12:37:50Z","description":null},{"id":97,"tag_name":"STATUS","tag_value":"[2.3.1.1] - Disease state-derived,Other,Affected,Patient","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":98,"tag_name":"STATUS","tag_value":"[2.3.1.2] - Disease state-derived,Other,Affected,Sibbling","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":99,"tag_name":"STATUS","tag_value":"[2.3.1.3] - Disease state-derived,Other,Affected,Mother","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":100,"tag_name":"STATUS","tag_value":"[2.3.1.4] - Disease state-derived,Other,Affected,Father","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":101,"tag_name":"STATUS","tag_value":"[2.3.1.5] - Disease state-derived,Other,Affected,Other relatives","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":102,"tag_name":"STATUS","tag_value":"[2.3.2.0] - Disease state-derived,Other,Not-affected","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":103,"tag_name":"STATUS","tag_value":"[2.3.2.1] - Disease state-derived,Other,Not-affected,Sibbling","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":104,"tag_name":"STATUS","tag_value":"[2.3.2.2] - Disease state-derived,Other,Not-affected,Mother","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":105,"tag_name":"STATUS","tag_value":"[2.3.2.3] - Disease state-derived,Other,Not-affected,Father","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":106,"tag_name":"STATUS","tag_value":"[2.3.2.4] - Disease state-derived,Other,Not-affected,Other relatives","tag_type":"SAMPLE_HIERARCHY","created_at":"2013-10-21T12:37:51Z","updated_at":"2013-10-21T12:37:51Z","description":null},{"id":107,"tag_name":"DISEASE","tag_value":"Severe Combined Immunodeficiency [C20.673.815]","tag_type":"MESH","created_at":"2013-10-21T12:59:46Z","updated_at":"2013-10-21T13:02:07Z","description":"Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID)."},{"id":108,"tag_name":"DISEASE","tag_value":"Leukocyte-Adhesion Deficiency Syndrome [C20.673.600]","tag_type":"MESH","created_at":"2013-10-21T13:00:43Z","updated_at":"2013-10-21T13:00:43Z","description":"Rare, autosomal recessive disorder caused by deficiency of the beta 2 integrin receptors ( RECEPTORS, LEUKOCYTE-ADHESION) comprising the CD11/CD18 family of glycoproteins. The syndrome is characterized by abnormal adhesion-dependent functions, especially defective tissue emigration of neutrophils, leading to recurrent infection."},{"id":109,"tag_name":"DISEASE","tag_value":"Lymphopenia [C20.673.627]","tag_type":"MESH","created_at":"2013-10-21T13:01:37Z","updated_at":"2013-10-21T13:01:37Z","description":"Reduction in the number of lymphocytes.\r\n"},{"id":110,"tag_name":"DISEASE","tag_value":"Leukemia, Myeloid, Acute [C04.557.337.539.275]","tag_type":"MESH","created_at":"2013-10-21T13:03:17Z","updated_at":"2013-12-02T11:43:16Z","description":"Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Encompasses Leukemia, Myeloblastic, Acute;Myeloid Leukemia, Acute, M0;Myeloid Leukemia, Acute, M1;Myeloid Leukemia, Acute, M2."},{"id":111,"tag_name":"TISSUE","tag_value":"DEFAULT","tag_type":"CUSTOM","created_at":"2013-12-15T15:22:47Z","updated_at":"2013-12-15T15:22:47Z","description":""},{"id":112,"tag_name":"DISEASE","tag_value":"DEFAULT","tag_type":"CUSTOM","created_at":"2013-12-15T15:22:57Z","updated_at":"2013-12-15T15:22:57Z","description":""},{"id":113,"tag_name":"STATUS","tag_value":"DEFAULT","tag_type":"CUSTOM","created_at":"2013-12-15T15:23:11Z","updated_at":"2013-12-15T15:23:11Z","description":""},{"id":114,"tag_name":"TISSUE","tag_value":"Blood Cells [A15.145.229]","tag_type":"MESH","created_at":"2013-10-21T13:07:17Z","updated_at":"2013-10-21T13:07:17Z","description":"general; prefer specifics; \"blood picture\" probably goes here or under BLOOD CELL COUNT"},{"id":115,"tag_name":"DISEASE","tag_value":"Down Syndrome [C16.320.180.260]","tag_type":"MESH","created_at":"2013-10-22T11:04:18Z","updated_at":"2013-10-22T11:04:18Z","description":"A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)"},{"id":116,"tag_name":"DISEASE","tag_value":"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma [C04.557.337.428.600.600]","tag_type":"MESH","created_at":"2013-10-22T11:07:51Z","updated_at":"2013-11-28T16:33:31Z","description":"A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.Pre-B ALL"},{"id":117,"tag_name":"DISEASE","tag_value":"Lymphoma, Large-Cell, Anaplastic [C15.604.515.569.480.487]","tag_type":"MESH","created_at":"2013-10-22T11:39:26Z","updated_at":"2013-10-22T11:41:14Z","description":"A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called \"hallmark\" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS."},{"id":118,"tag_name":"TISSUE","tag_value":"Lymphoid Tissue [A15.382.520.604]","tag_type":"MESH","created_at":"2013-10-22T11:44:12Z","updated_at":"2013-10-22T11:44:12Z","description":"Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS."},{"id":119,"tag_name":"DISEASE","tag_value":"Blood Platelet Disorders [C15.378.140]","tag_type":"MESH","created_at":"2013-11-05T13:00:48Z","updated_at":"2013-11-05T13:00:48Z","description":"Disorders caused by abnormalities in platelet count or function."},{"id":120,"tag_name":"DISEASE","tag_value":"Thrombocytopenia [C15.378.140.855]","tag_type":"MESH","created_at":"2013-11-05T13:05:07Z","updated_at":"2013-11-05T13:05:07Z","description":"A subnormal level of BLOOD PLATELETS."},{"id":121,"tag_name":"DISEASE","tag_value":"Agammaglobulinemia [C20.673.088]","tag_type":"MESH","created_at":"2013-11-05T13:08:26Z","updated_at":"2013-11-05T13:08:26Z","description":"An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood."},{"id":122,"tag_name":"DISEASE","tag_value":"Job's Syndrome [C20.673.774.600]","tag_type":"MESH","created_at":"2013-11-05T13:11:06Z","updated_at":"2013-11-05T13:11:06Z","description":"Primary immunodeficiency syndrome characterized by recurrent infections and hyper IgE. Most cases are sporadic. Of the rare familial forms, the dominantly inherited subtype has additional connective tissue, dental and skeletal involvement,syn.Hyper IgE-Sy"},{"id":123,"tag_name":"DISEASE","tag_value":"Hemorrhage [C23.550.414]","tag_type":"MESH","created_at":"2013-11-05T13:12:58Z","updated_at":"2013-11-05T13:12:58Z","description":"GEN or unspecified; prefer specifics; coord IM with organ/dis precoord (IM), not organ / blood supply; consider also terms for presence of blood within cavities, as HEMOTHORAX; HEMATOCOLPOS; etc."},{"id":124,"tag_name":"DISEASE","tag_value":"Neutropenia [C15.378.553.546.184.564]","tag_type":"MESH","created_at":"2013-11-05T13:15:44Z","updated_at":"2013-11-05T13:15:44Z","description":"A decrease in the number of NEUTROPHILS found in the blood."},{"id":125,"tag_name":"DISEASE","tag_value":"Developmental Disabilities [F03.550.362]","tag_type":"MESH","created_at":"2013-11-05T13:19:42Z","updated_at":"2013-11-05T13:19:42Z","description":"Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments/disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial..."},{"id":126,"tag_name":"DISEASE","tag_value":"Autistic Disorder [F03.550.325.125]","tag_type":"MESH","created_at":"2013-11-05T13:21:06Z","updated_at":"2013-11-05T13:21:06Z","description":"A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly"},{"id":127,"tag_name":"DISEASE","tag_value":"Immunologic Deficiency Syndromes [C20.673]","tag_type":"MESH","created_at":"2013-11-05T13:24:35Z","updated_at":"2013-11-05T13:24:35Z","description":"Immunological Deficiency Syndromes"},{"id":128,"tag_name":"DISEASE","tag_value":"Autoimmune Diseases [C20.111]","tag_type":"MESH","created_at":"2013-11-05T13:26:51Z","updated_at":"2013-11-05T13:26:51Z","description":"Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease"},{"id":129,"tag_name":"DISEASE","tag_value":"Pulmonary Blastoma [C04.557.435.675]","tag_type":"MESH","created_at":"2013-11-05T13:29:55Z","updated_at":"2013-11-05T13:29:55Z","description":"A malignant neoplasm of the lung composed chiefly or entirely of immature undifferentiated cells (i.e., blast forms) with little or virtually no stroma. (From Stedman, 25th ed).syn.\tPulmonary Blastomas"},{"id":130,"tag_name":"DISEASE","tag_value":"Autoimmune Lymphoproliferative Syndrome [C20.683.515.124]","tag_type":"MESH","created_at":"2013-11-14T15:30:45Z","updated_at":"2013-11-14T15:30:45Z","description":"Rare congenital lymphoid disorder due to mutations in certain Fas-Fas ligand pathway genes. Known causes include mutations in FAS, TNFSF6, NRAS, CASP8, and CASP10 proteins. Clinical features include LYMPHADENOPATHY; SPLENOMEGALY; and AUTOIMMUNITY."},{"id":132,"tag_name":"DISEASE","tag_value":"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma [C04.557.337.428.600.620]","tag_type":"MESH","created_at":"2013-11-14T15:49:11Z","updated_at":"2013-11-28T16:39:08Z","description":"A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.Leukemia, T-Cell, Acut"},{"id":133,"tag_name":"TISSUE","tag_value":"Mesenchymal Stromal Cells [A11.872.590.500]","tag_type":"MESH","created_at":"2013-11-14T15:51:44Z","updated_at":"2013-11-14T15:51:44Z","description":"Bone-marrow-derived, non-hematopoietic cells that support HEMATOPOETIC STEM CELLS. They have also been isolated from other organs and tissues such as UMBILICAL CORD BLOOD, umbilical vein subendothelium, and WHARTON JELLY. These cells are considered to be "},{"id":134,"tag_name":"TISSUE","tag_value":"Fibroblasts [A11.329.228]","tag_type":"MESH","created_at":"2013-11-14T15:54:14Z","updated_at":"2013-11-14T15:54:14Z","description":"Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules."},{"id":135,"tag_name":"DISEASE","tag_value":"Ataxia Telangiectasia [C16.320.080]","tag_type":"MESH","created_at":"2013-11-14T15:57:34Z","updated_at":"2013-11-14T15:57:34Z","description":"An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATIO"},{"id":136,"tag_name":"DISEASE","tag_value":"Ataxia Telangiectasia [C18.452.284.060]","tag_type":"MESH","created_at":"2013-11-14T15:58:29Z","updated_at":"2013-11-14T15:58:29Z","description":"An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATIO"},{"id":137,"tag_name":"DISEASE","tag_value":"Ataxia Telangiectasia [C20.673.290]","tag_type":"MESH","created_at":"2013-11-14T15:59:17Z","updated_at":"2013-11-14T15:59:17Z","description":"An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATIO"},{"id":140,"tag_name":"DISEASE","tag_value":"Burkitt Lymphoma [C15.604.515.569.480.150.165]","tag_type":"MESH","created_at":"2013-11-26T09:03:12Z","updated_at":"2013-11-26T09:03:12Z","description":"A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the i"},{"id":141,"tag_name":"DISEASE","tag_value":"Lymphoma, Primary Effusion [C15.604.515.569.480.150.592]","tag_type":"MESH","created_at":"2013-11-26T09:09:43Z","updated_at":"2013-11-26T09:09:43Z","description":"A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occ"},{"id":142,"tag_name":"DISEASE","tag_value":"Lymphoma, Large B-Cell, Diffuse [C15.604.515.569.480.150.585]","tag_type":"MESH","created_at":"2013-11-26T09:12:41Z","updated_at":"2013-11-26T09:18:37Z","description":"Malig.lymphoma composed of large Blymphoid c.w./nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse.DLBCL,diffuse large B-cell lymphoma"},{"id":143,"tag_name":"DISEASE","tag_value":"Leukemia, Megakaryoblastic, Acute [C04.557.337.539.275.450]","tag_type":"MESH","created_at":"2013-11-28T16:10:20Z","updated_at":"2013-11-28T16:10:20Z","description":"An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. MYELOFIBROSIS or increased bone marrow RETICULIN is common.\tMyeloid Leukemia, Acute, M7,Leukemia, Megakaryocytic, Acute"},{"id":144,"tag_name":"DISEASE","tag_value":"Leukemia, Monocytic, Acute [C04.557.337.539.275.484]","tag_type":"MESH","created_at":"2013-11-28T16:14:33Z","updated_at":"2013-11-28T16:14:33Z","description":"An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES.\tLeukemia, Myeloid, Acute, M5"},{"id":145,"tag_name":"DISEASE","tag_value":"Leukemia, Myelomonocytic, Acute [C04.557.337.539.520]","tag_type":"MESH","created_at":"2013-11-28T16:22:48Z","updated_at":"2013-11-28T16:22:48Z","description":"A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.\tMyeloid Leukemia, Acute, M4;Myelomonocytic Leukemia, Acute"},{"id":146,"tag_name":"DISEASE","tag_value":"Leukemia,Myelomonocytic, Juvenile [C04.557.337.539.525]","tag_type":"MESH","created_at":"2013-11-28T16:25:05Z","updated_at":"2013-11-28T16:25:05Z","description":"A leukemia affecting young children characterized by SPLENOMEGALY, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.JMML"},{"id":147,"tag_name":"DISEASE","tag_value":"Leukemia, Myelogenous,Chronic, BCR-ABL Positive [C04.557.337.539.250]","tag_type":"MESH","created_at":"2013-11-28T16:27:57Z","updated_at":"2013-11-28T16:27:57Z","description":"Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. CML,Leukemia, Chronic Myeloid.Leukemia, Myeloid, Philadelphia-Positive"},{"id":148,"tag_name":"DISEASE","tag_value":"Leukemia, Biphenotypic, Acute [C04.557.337.428.100]","tag_type":"MESH","created_at":"2013-11-28T16:43:44Z","updated_at":"2013-11-28T16:43:44Z","description":"An acute leukemia exhibiting cell features characteristic of both the myeloid and lymphoid lineages and probably arising from MULTIPOTENT STEM CELLS.\tAcute Biphenotypic Leukemia.Leukemia, Mixed, B- and T-Cell.Leukemia, Mixed-Cell"},{"id":149,"tag_name":"DISEASE","tag_value":"Leukemia, undifferentiated [C04.557.337]","tag_type":"MESH","created_at":"2014-01-16T14:55:27Z","updated_at":"2014-01-16T14:55:27Z","description":"PLEASE USE SPECIFC TERMS PREFERABLY. USE ONLY IF LEUKEMIA IS NOT SPECIFIED OF FAB TYPE \"AUL\".\r\ngeneral or unspecified; many specific leukemia types are available"}]